companydata.dkcompanydata.dk

Pharma Score Software A/S: Financial statements 2022

CVR: 39571536

Source: annual report 2022, Danish Business Authority

01/10/202130/09/2022

Pharma Score Software A/S (CVR 39571536) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -240,207 and a net result of DKK -346,568 compared with DKK -284,638 the year before. Equity in the 2022 report amounted to DKK -552,762. The company had 1 employee in the financial year.

Gross Profit
DKK -240,207
Profit/Loss
DKK -346,568
Equity
DKK -552,762
Total Assets
DKK 333,958
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--240 t.-347 t.-553 t.1
2021--214 t.-285 t.-206 t.1
2020--562 t.-842 t.78 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Pharma Score Software A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Carlo Wang Fung Chow steps down as chairman of Pharma Score Software A/SDec 31, 2022

As of December 31, 2022, Carlo Wang Fung Chow has stepped down as chairman of Pharma Score Software A/S.

Pharma Score Software A/S: The 2021 annual report is outMar 4, 2022

Pharma Score Software A/S has published its annual report for 2021. Gross profit came to DKK -214,024, and the net result was DKK -284,638.

About Pharma Score Software A/S

Pharma Score Software A/S was a Danish company of the type Aktieselskab based in Valby, founded in 2018. The company has been dissolved on 24 February 2025. The company was registered under the industry Computerprogrammering. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -126,512 and a net result of DKK -153,446 compared with DKK -346,568 the year before. Equity in the 2023 report amounted to DKK -706,208.

Source: annual report 2023, Danish Business Authority

Other financial years